| Financial Year |
March 31 2023 |
| Monetary Funds |
518,887,230.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
80,904,070.15 |
| Accounts Receivable |
508,722,388.51 |
| Advances to Suppliers |
117,936,160.17 |
| Other Receivables |
7,285,979.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
267,756,080.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,695,637.66 |
| Total Current Assets |
1,739,594,541.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
433,440,417.64 |
| Under-construction Projects |
27,635,800.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,095,642.78 |
| R&D expenses |
-- |
| Goodwill |
769,559.75 |
| Long-Term Deferred and Prepaid Expenses |
1,137,880.21 |
| Deferred Income Tax Assets |
17,190,689.08 |
| Other Non-Current Assets |
4,629,066.94 |
| Sub-Total of Non-Current Assets |
592,943,018.66 |
| Total Assets |
2,332,537,560.57 |
| Short-Term Loans |
110,113,056.63 |
| Trading Financial liabilities |
3,313.03 |
| Notes Payable |
582,520,000.00 |
| Accounts Payable |
122,791,302.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,801,851.63 |
| Taxes Payable |
6,175,612.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
273,724.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,172,952.05 |
| Other Current Liabilities |
3,946,776.97 |
| Sub-Total of Current Liabilities |
889,158,413.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,055,399.05 |
| Total Liabilities |
923,213,812.25 |
| Paid-In Capital(Or Share Stock) |
138,666,667.00 |
| Capital Surplus |
683,849,430.15 |
| Surplus Reserve |
59,986,432.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
522,364,241.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,409,323,748.32 |
| Owner's Equity（Stockholder's Equity） |
1,409,323,748.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,332,537,560.57 |
